Effect of Drug
2
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
MSDDocetaxel
Fosun PharmaORIN1001
City TherapeuticsPropofol
Clinical Trials (3)
Total enrollment: 177 patients across 3 trials
Docetaxel/Pembrolizumab in Head and Neck Squamous Cell Carcinoma
Start: Jul 2022Est. completion: Nov 202527 patients
Phase 2Active Not Recruiting
Treatment of Patients With Advanced Solid Tumors With Oral Agent ORIN1001 and in Combination With Standard of Care.
Start: Jul 2020Est. completion: Jan 2025150 patients
Phase 1/2Completed
Propofol Dose-Finding for Colonoscope Insertion in Geriatric Patients
Start: Sep 2025Est. completion: Oct 2025
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.